Satellite Banner
Technology Networks Header
Saturday, August 30, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Exiqon Releases New Online Search Tool for Gene Expression Studies
Thursday, February 06, 2014
New version of miRSearch for rapid retrieval of detailed information about microRNA.

Wako Life Sciences Receives AACC Award
Tuesday, February 04, 2014
Dr. Shinji Satomura and Dr. Henry Wada receives the award for the uTASWako i30 Immunoanalyzer.

Roche Announces the Launch of SeqCap Epi Target Enrichment System
Saturday, February 01, 2014
Novel NGS target enrichment solution for methylation assessment.

First Blood Collection Tube for IVD Genomic DNA Testing Now Available
Wednesday, January 29, 2014
BD launches the PAXgene® Blood DNA Tube in Europe.

Hamilton Robotics Launches NIMBUS PCR Workstation
Monday, January 27, 2014
Compact liquid handling workstation is flexible enough to change with users PCR assays.

PerkinElmer Introduces Novel Research Tools at SLAS 2014
Monday, January 27, 2014
PerkinElmer Inc. introduced several novel products at SLAS2014, including the Opera® Phenix™ high content screening system, JANUS® chemagic nucleic acid workstation.

Fluxion Biosciences Releases IsoFlux Rare Cell Enrichment Kit
Tuesday, January 21, 2014
New bead chemistry enables more options for targeted cell enrichment.

Talk to Tecan @ SLAS2014
Thursday, January 16, 2014
Tecan to discover the latest developments in automated liquid handling.

Massachusetts General Hospital Adopts Advanced Analytical Technology in Fight Against Cancer
Thursday, January 16, 2014
Company's Fragment Analyzer evaluates DNA and RNA of cancer patients.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 707
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv